Argos Therapeutics (FRA:77AA) Capex-to-Revenue : 0.00 (As of Sep. 2018)

Argos Therapeutics Capex-to-Revenue Chart

Argos Therapeutics Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
Capex-to-Revenue		Get a 7-Day Free Trial				0.14	0.56	18.68	16.22	1.94

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Capex-to-Revenue	Get a 7-Day Free Trial															1.43	-	-	-	-

Competitive Comparison of Argos Therapeutics's Capex-to-Revenue

For the Biotechnology subindustry, Argos Therapeutics's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argos Therapeutics's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argos Therapeutics's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Argos Therapeutics's Capex-to-Revenue falls into.

Argos Therapeutics Capex-to-Revenue Calculation

Argos Therapeutics's Capex-to-Revenue for the fiscal year that ended in Dec. 2017 is calculated as

Argos Therapeutics's Capex-to-Revenue for the quarter that ended in Sep. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Argos Therapeutics  (FRA:77AA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Argos Therapeutics Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description